| 2025 | 2024 | 2023 | 2022 | 2021 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 293,5 k € | -25.2% | 392,4 k € | +31.5% | 298,4 k € | +18.3% | 252,3 k € | +18.0% | 213,8 k € | +35.5% | 157,8 k € | -0.8% | 159,0 k € | +4.1% | 152,7 k € | +14.0% | 133,9 k € | +37.4% | 97,5 k € | +10.8% | 87,9 k € | -34.3% | 133,8 k € | +31.3% | 101,9 k € | -2.7% | 104,8 k € | +39.7% | 75,0 k € | |
| EBITDA | 292,3 k € | -25.3% | 391,2 k € | +31.8% | 296,9 k € | +18.2% | 251,3 k € | +18.2% | 212,5 k € | +49.5% | 142,2 k € | -8.9% | 156,1 k € | +6.3% | 146,9 k € | +102.7% | 72,5 k € | -24.3% | 95,7 k € | +14.5% | 83,6 k € | -36.3% | 131,2 k € | +30.4% | 100,6 k € | -2.8% | 103,5 k € | +41.4% | 73,2 k € | |
| Operating profit | 278,3 k € | -26.7% | 379,5 k € | +37.3% | 276,3 k € | +20.5% | 229,3 k € | +26.9% | 180,6 k € | +60.2% | 112,7 k € | -16.3% | 134,8 k € | +8.4% | 124,3 k € | +126.0% | 55,0 k € | -35.8% | 85,7 k € | +19.9% | 71,5 k € | -40.8% | 120,9 k € | +34.6% | 89,8 k € | -3.7% | 93,3 k € | +45.2% | 64,2 k € | |
| Profit/loss | 190,3 k € | -26.8% | 260,0 k € | +41.1% | 184,2 k € | +15.3% | 159,8 k € | +23.1% | 129,8 k € | +75.0% | 74,2 k € | +2.4% | 72,4 k € | -42.8% | 126,6 k € | +111.8% | 59,8 k € | -0.3% | 59,9 k € | +20.0% | 49,9 k € | -32.5% | 73,9 k € | +62.7% | 45,4 k € | -30.1% | 65,0 k € | +51.2% | 43,0 k € | |
| Equity | 810,4 k € | -2.0% | 827,0 k € | +25.7% | 658,0 k € | +5.2% | 625,7 k € | -18.4% | 766,9 k € | +203.8% | 252,4 k € | +41.6% | 178,2 k € | -32.9% | 265,8 k € | -45.0% | 483,2 k € | +14.1% | 423,5 k € | +16.5% | 363,6 k € | +15.9% | 313,7 k € | +30.8% | 239,7 k € | +23.4% | 194,3 k € | +50.3% | 129,3 k € | |
| Total assets | 869,2 k € | -12.7% | 995,6 k € | +9.9% | 905,7 k € | +6.4% | 850,9 k € | -2.2% | 870,1 k € | +45.4% | 598,3 k € | -8.9% | 656,7 k € | +16.7% | 562,8 k € | -30.6% | 811,1 k € | +75.5% | 462,1 k € | +11.2% | 415,7 k € | +2.2% | 407,0 k € | +15.2% | 353,2 k € | +10.5% | 319,5 k € | +29.3% | 247,2 k € | |
| Cash | 6,4 k € | +26.4% | 5,1 k € | -18.7% | 6,2 k € | -23.6% | 8,1 k € | -21.9% | 10,4 k € | -52.5% | 22,0 k € | +57.6% | 13,9 k € | -5.1% | 14,7 k € | -86.2% | 106,1 k € | +2.3% | 103,7 k € | +5.1% | 98,6 k € | -1.0% | 99,6 k € | +275.7% | 26,5 k € | +73.7% | 15,3 k € | +3.1% | 14,8 k € | |
| Debts | 58,7 k € | -65.2% | 168,7 k € | -31.3% | 245,6 k € | +9.1% | 225,2 k € | +118.3% | 103,2 k € | -70.2% | 345,9 k € | -27.7% | 478,5 k € | +61.1% | 297,0 k € | -9.4% | 327,8 k € | +748.1% | 38,7 k € | -25.9% | 52,2 k € | -44.1% | 93,3 k € | -17.7% | 113,4 k € | -9.4% | 125,2 k € | +6.2% | 117,9 k € | |
Private limited company · Herselt · incorporated on 07/11/1988
Private limited company profitable and well capitalised. Cash position rising (+26.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. PAUL DE LOORE is a Private limited company incorporated in 1988. Its main activity is: General medical practice activities. Its registered office is in Herselt.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette